Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system

Fig. 3

Disproportionality analysis. The Forest plot shows proportional reporting ratios (PRR) with 95% confidence intervals (CI) for atrial fibrillation (AF) in reports for sodium glucose cotransporter-2 inhibitors (SGLT2i) versus control drugs. A PRR < 1.0 indicates a disproportional lower rate of AF among reports for SGLT2i. ATC anatomic therapeutic classification, AE adverse event, CVD cardiovascular disease, RD renal disease

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840